Is a complete LAB research report available?

No complete published report is available for Standard BioTools Inc. (LAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Standard BioTools Inc. (LAB)

NASDAQ: LAB · USD

$0.62

+0.00 (+0.3%)· Recorded snapshot

Market cap	242.6M
Revenue (ttm)	84.6M
Net income (ttm)	84.9M
EPS (ttm)	$0.22
Shares out	392.6M
P/E (trailing)	2.8x
Volume	704,525
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 84.6M
Net income (ttm): 84.9M
EPS (ttm): $0.22
P/E (trailing): 2.8x
Market cap: 242.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001162194
Company name	Standard BioTools Inc.
Country	United States
Country code	US
CUSIP number	34385P108
Earnings date	2026-11-10
Earnings time	amc
Employees	389
Employees change	-429
Employees growth	-52.44%
Enterprise value	$-206M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Medical Devices
IPO date	2011-02-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US34385P1084
Last 10-K release date	2026-03-16
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$242.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$0.62
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LAB
U.S. state	Massachusetts
Website	https://www.standardbio.com

Metric

Value

Amount currency

USD

CIK code

0001162194

Company name

Standard BioTools Inc.

Country

United States

Country code

CUSIP number

34385P108

Earnings date

2026-11-10

Earnings time

amc

Employees

389

Employees change

-429

Employees growth

-52.44%

Enterprise value

$-206M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1999

Industry

Medical Devices

IPO date

2011-02-10

Is primary listing

Yes

Is SPAC

ISIN number

US34385P1084

Last 10-K release date

2026-03-16

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$242.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$0.62

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LAB

U.S. state

Massachusetts

Website

https://www.standardbio.com

Metric	Value
Earnings yield	35.53%
FCF / EV yield	39.94%
FCF yield	-34.14%
Forward P/S	2.94x
Graham number	2.6082
Graham upside	323.34%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.45x
P/E ratio	2.81x
P/S ratio	2.86x
Price / tangible book value	0.45x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

35.53%

FCF / EV yield

39.94%

FCF yield

-34.14%

Forward P/S

2.94x

Graham number

2.6082

Graham upside

323.34%

Industry forward P/E

19.74x

Industry P/E

39.16x

P/B ratio

0.45x

P/E ratio

2.81x

P/S ratio

2.86x

Price / tangible book value

0.45x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-74.04%
EBITDA margin	-62.74%
Gross margin	50.49%
Operating margin	-74.04%
Pretax margin	-107.55%
Profit margin	100.37%
Profit per employee	$218,267
Revenue per employee	$217,473
ROA	-6.61%
ROA (5Y)	-13.04%
ROCE	-10.98%
ROE	-11.18%
ROE (5Y)	-49.54%
ROIC	-7.67%
SBC / revenue	32.02%
Tax / revenue	-43.79%

Metric

Value

EBIT margin

-74.04%

EBITDA margin

-62.74%

Gross margin

50.49%

Operating margin

-74.04%

Pretax margin

-107.55%

Profit margin

100.37%

Profit per employee

$218,267

Revenue per employee

$217,473

ROA

-6.61%

ROA (5Y)

-13.04%

ROCE

-10.98%

ROE

-11.18%

ROE (5Y)

-49.54%

ROIC

-7.67%

SBC / revenue

32.02%

Tax / revenue

-43.79%

Metric	Value
EPS growth quarters	3
EPS growth years	3
Gross profit growth	-5.43%
Gross profit growth (Q)	-0.88%
Gross profit growth 3Y	-10.46%
Gross profit growth 5Y	-2.1%
Net income growth quarters	3
Net income growth years	1
Revenue growth	-4.78%
Revenue growth (Q)	-7.62%
Revenue growth (QoQ)	-4.93%
Revenue growth 10Y	-3.15%
Revenue growth 3Y	-7.08%
Revenue growth 5Y	-10.62%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-5.43%

Gross profit growth (Q)

-0.88%

Gross profit growth 3Y

-10.46%

Gross profit growth 5Y

-2.1%

Net income growth quarters

Net income growth years

Revenue growth

-4.78%

Revenue growth (Q)

-7.62%

Revenue growth (QoQ)

-4.93%

Revenue growth 10Y

-3.15%

Revenue growth 3Y

-7.08%

Revenue growth 5Y

-10.62%

Revenue growth years

Metric	Value
Capital expenditures	$-2.3M
Depreciation and amortization	$9.6M
EBIT	$-62.6M
EBITDA	$-53.1M
EPS	$0.22
FCF per share	$-0.21
Financing cash flow	$330,000
Free cash flow	$-82.6M
Free cash flow minus SBC	$-109.7M
Gross profit	$42.7M
Income taxes	$-37M
Investing cash flow	$190.8M
Net cash flow	$110.9M
Net income	$84.9M
Operating cash flow minus SBC	$-107.4M
Operating income	$-62.6M
Revenue	$84.6M
Stock-based compensation	$27.1M

Metric

Value

Capital expenditures

$-2.3M

Depreciation and amortization

$9.6M

EBIT

$-62.6M

EBITDA

$-53.1M

EPS

$0.22

FCF per share

$-0.21

Financing cash flow

$330,000

Free cash flow

$-82.6M

Free cash flow minus SBC

$-109.7M

Gross profit

$42.7M

Income taxes

$-37M

Investing cash flow

$190.8M

Net cash flow

$110.9M

Net income

$84.9M

Operating cash flow minus SBC

$-107.4M

Operating income

$-62.6M

Revenue

$84.6M

Stock-based compensation

$27.1M

Metric	Value
Altman Z-Score	1.28
Book value per share	$1.38
Debt / equity	0.05
Interest coverage	-2,409.08
Long-term assets	$110.4M
Long-term liabilities	$30.4M
Net cash (debt)	$448.6M
Net cash / market cap	185.49%
Net cash growth	115.2%
Net debt / equity	-0.83
Piotroski F-Score	3
Property, plant and equipment	$39.5M
Shareholders' equity	$540M
Tangible book value	$540M
Tangible book value per share	$1.38
Total assets	$627.2M
Total cash	$476.7M
Total debt	$28.1M
Total liabilities	$87.2M
WACC	10.48%

Metric

Value

Altman Z-Score

1.28

Book value per share

$1.38

Debt / equity

0.05

Interest coverage

-2,409.08

Long-term assets

$110.4M

Long-term liabilities

$30.4M

Net cash (debt)

$448.6M

Net cash / market cap

185.49%

Net cash growth

115.2%

Net debt / equity

-0.83

Piotroski F-Score

Property, plant and equipment

$39.5M

Shareholders' equity

$540M

Tangible book value

$540M

Tangible book value per share

$1.38

Total assets

$627.2M

Total cash

$476.7M

Total debt

$28.1M

Total liabilities

$87.2M

WACC

10.48%

Metric	Value
Asset turnover	0.14
Current assets	$516.9M
Current liabilities	$56.8M
Current ratio	9.1
Inventory turnover	2.03
Net working capital	$-11M
Quick ratio	8.67
Working capital	$460.1M
Working capital turnover	0.19

Metric

Value

Asset turnover

0.14

Current assets

$516.9M

Current liabilities

$56.8M

Current ratio

9.1

Inventory turnover

2.03

Net working capital

$-11M

Quick ratio

8.67

Working capital

$460.1M

Working capital turnover

0.19

Metric	Value
Buyback yield / dilution	-2.76%
Dividend yield	0%
Shareholder yield	-2.76%

Metric

Value

Buyback yield / dilution

-2.76%

Dividend yield

Shareholder yield

-2.76%

Metric	Value
10Y price change	-86.38%
10Y return CAGR	-18.08%
10Y total return	-86.38%
150-day SMA	$0.83
15Y price change	-95.82%
15Y return CAGR	-19.08%
15Y total return	-95.82%
1D price change	0.31%
1M price change	-17.52%
1M total return	-17.52%
1W price change	-4.24%
1W total return	-4.24%
1Y price change	-53.77%
1Y return CAGR	-53.79%
1Y total return	-53.77%
20-day SMA	$0.66
200-day SMA	$0.93
3M price change	-21.21%
3M total return	-21.21%
3Y price change	-66.47%
3Y return CAGR	-30.52%
3Y total return	-66.47%
50-day SMA	$0.68
50-day SMA vs 200-day SMA	50under200
52-week high	$1.72
52-week high date	2025-12-22
52-week low	$0.59
52-week low date	2026-10-27
5Y price change	-87.77%
5Y return CAGR	-34.32%
5Y total return	-87.77%
6M price change	-32.08%
6M total return	-32.08%
All-time high	$49.46
All-time high date	2014-02-27
All-time low	$0.59
All-time low date	2026-10-27
Average true range (ATR)	$0.04
Average volume	864.7K
Beta (1Y)	1.42
Beta (2Y)	1.47
Beta (5Y)	1.35
Change from 52-week high	-64.07%
Change from 52-week low	5.08%
Change from all-time high	-98.77%
Change from all-time low	3.77%
Change from open	-0.32%
Day's gap	0.63%
Dollar volume	$435,396
High price	$0.62
Low price	$0.61
Monthly RSI	36.45
Open price	$0.62
Position in 52-week range	76.64%
Premarket change	0.63%
Premarket close	$0.62
Premarket price	$0.62
Previous close	$0.62
Price vs 150-day SMA	-26.58%
Price vs 20-day SMA	-7.74%
Price vs 200-day SMA	-34.05%
Price vs 50-day SMA	-10.51%
Relative volume	0.81
RSI	38.07
Sharpe ratio	-0.84
Sharpe ratio (3Y)	-0.24
Sharpe ratio (5Y)	-0.2
Sortino ratio	-1.05
Sortino ratio (3Y)	-0.26
Sortino ratio (5Y)	-0.22
Volume	704.5K
Weekly RSI	35.87
YTD price change	-52.32%
YTD total return	-52.32%

Metric

Value

10Y price change

-86.38%

10Y return CAGR

-18.08%

10Y total return

-86.38%

150-day SMA

$0.83

15Y price change

-95.82%

15Y return CAGR

-19.08%

15Y total return

-95.82%

1D price change

0.31%

1M price change

-17.52%

1M total return

-17.52%

1W price change

-4.24%

1W total return

-4.24%

1Y price change

-53.77%

1Y return CAGR

-53.79%

1Y total return

-53.77%

20-day SMA

$0.66

200-day SMA

$0.93

3M price change

-21.21%

3M total return

-21.21%

3Y price change

-66.47%

3Y return CAGR

-30.52%

3Y total return

-66.47%

50-day SMA

$0.68

50-day SMA vs 200-day SMA

50under200

52-week high

$1.72

52-week high date

2025-12-22

52-week low

$0.59

52-week low date

2026-10-27

5Y price change

-87.77%

5Y return CAGR

-34.32%

5Y total return

-87.77%

6M price change

-32.08%

6M total return

-32.08%

All-time high

$49.46

All-time high date

2014-02-27

All-time low

$0.59

All-time low date

2026-10-27

Average true range (ATR)

$0.04

Average volume

864.7K

Beta (1Y)

1.42

Beta (2Y)

1.47

Beta (5Y)

1.35

Change from 52-week high

-64.07%

Change from 52-week low

5.08%

Change from all-time high

-98.77%

Change from all-time low

3.77%

Change from open

-0.32%

Day's gap

0.63%

Dollar volume

$435,396

High price

$0.62

Low price

$0.61

Monthly RSI

36.45

Open price

$0.62

Position in 52-week range

76.64%

Premarket change

0.63%

Premarket close

$0.62

Premarket price

$0.62

Previous close

$0.62

Price vs 150-day SMA

-26.58%

Price vs 20-day SMA

-7.74%

Price vs 200-day SMA

-34.05%

Price vs 50-day SMA

-10.51%

Relative volume

0.81

RSI

38.07

Sharpe ratio

-0.84

Sharpe ratio (3Y)

-0.24

Sharpe ratio (5Y)

-0.2

Sortino ratio

-1.05

Sortino ratio (3Y)

-0.26

Sortino ratio (5Y)

-0.22

Volume

704.5K

Weekly RSI

35.87

YTD price change

-52.32%

YTD total return

-52.32%

Metric	Value
Float	185.7M
Float percentage	47.3%
Shares change (QoQ)	0.69%
Shares change (YoY)	2.76%
Shares held by insiders	1.82%
Shares held by institutions	24.43%
Shares outstanding	392.6M
Short % of float	1.36%
Short % of shares	0.64%
Short ratio	1.8 days

Metric

Value

Float

185.7M

Float percentage

47.3%

Shares change (QoQ)

0.69%

Shares change (YoY)

2.76%

Shares held by insiders

1.82%

Shares held by institutions

24.43%

Shares outstanding

392.6M

Short % of float

1.36%

Short % of shares

0.64%

Short ratio

1.8 days

Standard BioTools Inc. (LAB)

Price

Financial snapshot

Fair-value bridge

Latest news · LAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LAB

Frequently asked questions